Personalised therapy for localised gastric and gastro-oesophageal adenocarcinoma

Brian Badgwell¹, Mariela Blum², Jeannelyn Estrella³, Jaffer Ajani²

Affiliations

¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: bbadgwell@mdanderson.org.
² Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
³ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

PMID: 27776842
DOI: 10.1016/S1470-2045(16)30521-6

Comment

Personalised therapy for localised gastric and gastro-oesophageal adenocarcinoma

Brian Badgwell et al. Lancet Oncol. 2016 Dec.

. 2016 Dec;17(12):1628-1629.

doi: 10.1016/S1470-2045(16)30521-6. Epub 2016 Oct 21.

Authors

Brian Badgwell¹, Mariela Blum², Jeannelyn Estrella³, Jaffer Ajani²

Affiliations

¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: bbadgwell@mdanderson.org.
² Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
³ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

PMID: 27776842
DOI: 10.1016/S1470-2045(16)30521-6

No abstract available

PubMed Disclaimer

Comment on

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Al-Batran SE, Hofheinz RD, Pauligk C, Kopp HG, Haag GM, Luley KB, Meiler J, Homann N, Lorenzen S, Schmalenberg H, Probst S, Koenigsmann M, Egger M, Prasnikar N, Caca K, Trojan J, Martens UM, Block A, Fischbach W, Mahlberg R, Clemens M, Illerhaus G, Zirlik K, Behringer DM, Schmiegel W, Pohl M, Heike M, Ronellenfitsch U, Schuler M, Bechstein WO, Königsrainer A, Gaiser T, Schirmacher P, Hozaeel W, Reichart A, Goetze TO, Sievert M, Jäger E, Mönig S, Tannapfel A. Al-Batran SE, et al. Lancet Oncol. 2016 Dec;17(12):1697-1708. doi: 10.1016/S1470-2045(16)30531-9. Epub 2016 Oct 22. Lancet Oncol. 2016. PMID: 27776843 Clinical Trial.

Cited by

miR-204-5p Suppress Lymph Node Metastasis via Regulating CXCL12 and CXCR4 in Gastric Cancer.
Zhang J, Xing L, Xu H, Wang K, She J, Shi F, Wu H, Sun Y, Gao J, He S. Zhang J, et al. J Cancer. 2020 Mar 5;11(11):3199-3206. doi: 10.7150/jca.33273. eCollection 2020. J Cancer. 2020. PMID: 32231725 Free PMC article.
Asporin represses gastric cancer apoptosis via activating LEF1-mediated gene transcription independent of β-catenin.
Zhang Z, Min L, Li H, Chen L, Zhao Y, Liu S, Guo Q, Zhu S, Li P, Zhang S. Zhang Z, et al. Oncogene. 2021 Jul;40(27):4552-4566. doi: 10.1038/s41388-021-01858-7. Epub 2021 Jun 14. Oncogene. 2021. PMID: 34127813
Systematic review and meta-analysis of docetaxel perioperative chemotherapy regimens in gastric and esophagogastric tumors.
Uson Junior PLS, Santos VM, Bugano DDG, Victor EDS, Rother ET, Maluf FC. Uson Junior PLS, et al. Sci Rep. 2019 Nov 1;9(1):15806. doi: 10.1038/s41598-019-52334-y. Sci Rep. 2019. PMID: 31676841 Free PMC article.
Krüppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.
Kong F, Sun T, Kong X, Xie D, Li Z, Xie K. Kong F, et al. Clin Cancer Res. 2018 May 15;24(10):2440-2451. doi: 10.1158/1078-0432.CCR-17-3346. Epub 2018 Jan 24. Clin Cancer Res. 2018. PMID: 29367428 Free PMC article.
VPAC1 couples with TRPV4 channel to promote calcium-dependent gastric cancer progression via a novel autocrine mechanism.
Tang B, Wu J, Zhu MX, Sun X, Liu J, Xie R, Dong TX, Xiao Y, Carethers JM, Yang S, Dong H. Tang B, et al. Oncogene. 2019 May;38(20):3946-3961. doi: 10.1038/s41388-019-0709-6. Epub 2019 Jan 28. Oncogene. 2019. Retraction in: Oncogene. 2025 Aug 6. doi: 10.1038/s41388-025-03525-7. PMID: 30692637 Retracted.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Personalised therapy for localised gastric and gastro-oesophageal adenocarcinoma

Affiliations

Personalised therapy for localised gastric and gastro-oesophageal adenocarcinoma

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical